Identification of High Fat Diet Induced Modulations of the Gut-Brain Pathways
高脂肪饮食诱导的肠-脑通路调节的鉴定
基本信息
- 批准号:10597789
- 负责人:
- 金额:$ 8.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2022-10-04
- 项目状态:已结题
- 来源:
- 关键词:AddressAdipose tissueAdverse effectsAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAnimal ModelAstrocytesAstrocytosisAwardBioinformaticsBiological AssayBlood GlucoseBrainCognitiveCommittee MembersDataDementiaDevelopmentDietDiseaseDoctor of PhilosophyDrug ControlsEnergy MetabolismEnvironmental Risk FactorEpidemicEventFatty acid glycerol estersFellowshipFunctional disorderFundingFutureGene ExpressionGene Expression ProfilingGene MutationGenesGenetic RiskGenotypeGlial Fibrillary Acidic ProteinGliosisGlucose IntoleranceGoalsHigh Fat DietImageImpaired cognitionInflammationInflammatoryInstitutionKnock-in MouseLeadLipidsMeasuresMetabolicMetabolic PathwayMetabolismMetforminMethodsMicrogliaMusNADHNADPNeurogliaNeuronsNon-Insulin-Dependent Diabetes MellitusObesityOnset of illnessOxidative StressPathologicPathway interactionsPeripheralPlasmaPopulationPositioning AttributePostdoctoral FellowProfessional OrganizationsProtocols documentationQuantitative Reverse Transcriptase PCRRNAReactive Oxygen SpeciesResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRisk FactorsRodent ModelStainsStimulusStructureSubcellular structureTimeTissuesTrainingVisceralWeight GainWestern BlottingWorkbrain pathwaycombinatorialgenetic risk factorimmunoreactivityinnovationinterestlipidomicsmetabolomicsmicroscopic imagingmouse modelnovel strategiesobese personoxidative damageresponseskillssymposiumsystemic inflammatory responsetranscriptomicswestern diet
项目摘要
Project Summary
APOE4 is the strongest genetic risk factor for Alzheimer’s Disease (AD) and obesity is one of the most common
environmental risk factors for AD. With 14% of the population being APOE4 carriers and 30% of the population
suffering from obesity, it is extremely important to understand how these two common AD risk factors interact.
We will analyze these interactions in healthy rodent models. Previous studies in mice have shown the
combination of obesity and APOE4 further exacerbates AD pathology and cognitive decline; the studies
proposed here aim at understanding alterations that occur before AD onset. APOE3 and APOE4 knock-in mice
were placed on high fat “western” diets (HFD, 45% fat) for 12 weeks starting at 6 months old. Aim 1a examined
the metabolic and cognitive disturbances associated with HFD and we found HFD increased metabolic
disturbances in APOE3 and APOE4 mice, with APOE4 mice being more susceptible. Aim 1b examined
effects of HFD on glial immunoreactivity, lipid droplet accumulation, and neuronal complexity. We found HFD
increased glia immunoreactivity and lipid droplet (LD) accumulation in APOE3 and APOE4 mice. The
remainder of my thesis will focus on identifying mechanisms underlying glia immunoreactivity and LD
accumulation and reducing HFD induced alterations. Aim 2a will examine parallel peripheral metabolic and
inflammatory pathways induced by HFD. We will investigate: 1) With HFD, are specific inflammatory or metabolic
genes altered? 2) Is there a correlation between the specific genes altered in the periphery and CNS with HFD?
3) Do the specific genes altered by HFD differ between APOE3 and APOE4 genotypes? Aim 2b will examine
whether LD composition differs between genotypes and diets, and if increases in LD accumulation is associated
with oxidative stress. We will investigate: 1) Does LD composition differ between APOE genotype and diet? 2)
Does LD accumulation correlate with increased oxidative stress? 3) Do LDs colocalize with reactive oxygen
species? Aim 2c will examine whether Metformin will ameliorate the LD accumulation and gliosis associated
with HFD. We will investigate: 1) Does Metformin reduce gliosis and LD accumulation? 2) Do LDs co-localize
with microglia or astrocytes? After completing my PhD, I will continue to build skills in a post-doctoral setting
researching the mechanisms underlying diet induced cognitive alterations through metabolomics and
transcriptomics. I will be successful in this through first identifying an ideal post-doctoral lab then obtaining the
post-doctoral position. My goal is to complete my post-doctoral fellowship at an institution that values
rigorous scientific research, innovation, training and professional development. To obtain this
fellowship, my sponsor and I have committed to a plan that includes identifying an ideal lab setting. We
have agreed to working with my committee members and collaborators, attending multiple conferences
and networking events, and inviting speakers. The F99/K00 will greatly assist me in both completing my PhD
and obtaining the postdoctoral position I am striving for.
项目概要
APOE4 是阿尔茨海默病 (AD) 最强的遗传风险因素,而肥胖是最常见的遗传风险因素之一
AD 的环境危险因素 14% 的人口是 APOE4 携带者,30% 的人口是 APOE4 携带者。
对于患有肥胖症的人来说,了解这两个常见的 AD 危险因素如何相互作用非常重要。
我们将在健康啮齿动物模型中分析这些相互作用,之前对小鼠的研究已经表明了这一点。
肥胖和 APOE4 的结合进一步加剧了 AD 病理和认知能力下降;
这里提出的目标是在 AD 理解发生之前发生的改变 APOE3 和 APOE4 敲入小鼠。
从 6 个月大时开始进行 12 周的高脂肪“西方”饮食(HFD,45% 脂肪)检查,目标 1a。
与 HFD 相关的代谢和认知障碍,我们发现 HFD 会增加代谢
APOE3 和 APOE4 小鼠中的干扰,其中 APOE4 小鼠更容易受到检查。
HFD 对神经胶质免疫反应性、脂滴积累和神经复杂性的影响。
APOE3 和 APOE4 小鼠的神经胶质细胞免疫反应性和脂滴 (LD) 积累增加。
我论文的其余部分将重点探讨神经胶质细胞免疫反应性和 LD 的潜在机制
目标 2a 将检查平行的外周代谢和变化。
我们将研究 HFD 引起的炎症途径:1) HFD 是特异性炎症或代谢途径。
2) 外周和中枢神经系统的特定基因改变与 HFD 之间是否存在相关性?
3) Aim 2b 将检查 APOE3 和 APOE4 基因型之间 HFD 改变的特定基因是否不同?
基因型和饮食之间的 LD 组成是否不同,以及 LD 积累的增加是否相关
我们将研究:1) APOE 基因型和饮食之间的 LD 组成是否不同?
LD 积累与氧化应激增加相关吗 3) LD 与活性氧共定位吗?
目标 2c 将检查二甲双胍是否会改善 LD 积累和相关神经胶质增生
我们将研究:1) 二甲双胍是否会减少神经胶质增生和 LD 积累?
完成博士学位后,我将继续在博士后环境中培养技能
通过代谢组学研究饮食引起认知改变的机制
我将通过首先确定一个理想的博士后实验室然后获得转录组学来取得成功。
我的目标是在一个重视的机构完成我的博士后奖学金。
严格的科学研究、创新、培训和专业发展才能获得这一点。
作为奖学金,我和我的赞助商已承诺制定一项计划,其中包括确定理想的实验室环境。
已同意与我的委员会成员和合作者合作,参加多个会议
和社交活动,以及邀请演讲者将极大地帮助我完成我的博士学位。
并获得我正在努力争取的博士后职位。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nahdia S Jones其他文献
APOE and immunity: Research highlights
APOE 和免疫:研究亮点
- DOI:
10.1002/alz.13020 - 发表时间:
2023-03-28 - 期刊:
- 影响因子:0
- 作者:
Courtney M. Kloske;C. Barnum;A. F. Batista;E. Bradshaw;A. Brickman;G. Bu;Jessica L. Dennison;Mary D Gearon;A. Goate;C. Haass;M. Heneka;William T. Hu;L. Huggins;Nahdia S Jones;R. Koldamova;C. Lemere;S. Liddelow;Edoardo Marcora;S. Marsh;H. Nielsen;Kellen K. Petersen;Melissa E. Petersen;S. Piña;W. Qiu;Y. Quiroz;E. Reiman;Claire E Sexton;M. Tansey;J. Tcw;C. Teunissen;B. Tijms;Rik van der Kant;Rebecca L. Wallings;S. Weninger;W. Wharton;D. Wilcock;Tyler J. Wishard;S. Worley;H. Zetterberg;M. Carrillo - 通讯作者:
M. Carrillo
Metabolic Disturbances of a High-Fat Diet Are Dependent on APOE Genotype and Sex
高脂肪饮食的代谢紊乱取决于 APOE 基因型和性别
- DOI:
10.1523/eneuro.0267-19.2019 - 发表时间:
2019-09-01 - 期刊:
- 影响因子:3.4
- 作者:
Nahdia S Jones;Katarina Q. Watson;William G. Rebeck - 通讯作者:
William G. Rebeck
The Synergistic Effects of APOE Genotype and Obesity on Alzheimer’s Disease Risk
APOE 基因型和肥胖对阿尔茨海默病风险的协同作用
- DOI:
10.3390/ijms20010063 - 发表时间:
2018-12-24 - 期刊:
- 影响因子:5.6
- 作者:
Nahdia S Jones;G. Rebeck - 通讯作者:
G. Rebeck
Nahdia S Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于“脂肪-肝脏对话”探讨脂肪组织代谢重编程相关活性代谢因子AMRM2调控RNF8/RXRα/PPARα轴在肝脏脂质代谢稳态维持中的作用与机制
- 批准号:82300971
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
巨噬细胞GP73-CXCL5调节脂肪组织适应性产热的机制研究
- 批准号:32300573
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
不同脂肪组织及其驻留巨噬细胞调控小鼠禁食稳态的系统研究
- 批准号:32301235
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脂肪干细胞外泌体miRNA-299a-3p调控巨噬细胞Thbs1缓解脂肪组织衰老的机制研究
- 批准号:82301753
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
棕色脂肪组织源外泌体circ-JARID2调控线粒体功能在延缓卵巢衰老中的作用及机制研究
- 批准号:82301848
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 8.46万 - 项目类别:
Microbiome Metabolite Valerobetaine: Mechanisms in Aging
微生物组代谢物戊甜菜碱:衰老机制
- 批准号:
10763615 - 财政年份:2023
- 资助金额:
$ 8.46万 - 项目类别:
Impact of Per/Polyfluoroalkyl pollutants on vascular disease mechanisms
全氟烷基/多氟烷基污染物对血管疾病机制的影响
- 批准号:
10751239 - 财政年份:2023
- 资助金额:
$ 8.46万 - 项目类别:
Signaling and metabolic functions of nSMase-2 in hepatic steatosis and onset of insulin resistance
nSMase-2 在肝脂肪变性和胰岛素抵抗发作中的信号传导和代谢功能
- 批准号:
10735117 - 财政年份:2023
- 资助金额:
$ 8.46万 - 项目类别:
Exosomes and insulin action in metabolically healthy and unhealthy obesity
外泌体和胰岛素在代谢健康和不健康肥胖中的作用
- 批准号:
10721302 - 财政年份:2023
- 资助金额:
$ 8.46万 - 项目类别: